Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression

22 Apr 2016

Abstract excerpt

// Ryan Stuchbery 1, 2, 4 , Geoff Macintyre 3 , Marek Cmero 3 , Laurence M. Harewood 2, 4 , Justin S. Peters 2, 4 , Anthony J. Costello 1, 2, 4 , Christopher M. Hovens 1, 2, 4 , Niall M. Corcoran 1, 2, 4 1 Australian Prostate Cancer Research Centre Epworth, Richmond, VIC, Australia 2 Department of Urology, Royal Melbourne Hospital and University of Melbourne, Parkville, VIC, Australia 3 NICTA Victoria Research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27120785
DOI: 10.18632/oncotarget.8915

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progressionPMID 27120785Read ↗

Decreased expression of MT1E is a potential biomarker of prostate cancer progressionSemantic proximity Read ↗

Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancerSemantic proximity Read ↗

Androgen receptor and prostate cancerSemantic proximity Read ↗

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseSemantic proximity Read ↗

Novel molecular aspects of prostate carcinogenesis.Semantic proximity Read ↗

Genomic hallmarks of localized, non-indolent prostate cancer.Semantic proximity Read ↗

Development and prevalence of castration-resistant prostate cancer subtypesSemantic proximity Read ↗

Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and ChallengesSemantic proximity Read ↗

The androgen receptor malignancy shift in prostate cancerSemantic proximity Read ↗

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studySemantic proximity Read ↗

Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics ApproachSemantic proximity Read ↗

Gene expression signature of castrate resistant prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.